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1. Introduction 
Schistosomiasis, or bilharzias, is a neglected disease that remains a considerable public 
health problem in tropical and subtropical regions. This parasitic disease is the most 
important human helminth infection in terms of morbidity and mortality and is a growing 
concern worldwide. It is estimated that more than 200 million people have been infected 
and that 779 million are at risk of infection, resulting in 280,000 deaths annually (van der 
Werf et al., 2003; Steinmann et al., 2006). Schistosomiasis is caused by blood-dwelling fluke 
worms of the genus Schistosoma and is endemic in African, Asian and South American 
countries. The main disease-causing species are S. mansoni, S. haematobium, and S. japonicum. 
S. mansoni is the most widely distributed, affecting people in Africa, the Middle East, South 
America, and the Caribbean, while S. japonicum is confined to China, Indonesia, and the 
Philippines. S. haematobium is found in Africa and the Middle East. The adult worms 
colonise the veins of either the portal system (S. mansoni and S. japonicum) or the urinary 
bladder plexus (S. haematobium) and can live for years or even decades in human hosts; thus, 
the disease runs a chronic and debilitating course. Egg production is responsible for both the 
transmission of the parasite and the aetiology of the disease. Schistosomal species are 
distinguished by differences in their morphology, both in their parasite stages and in their 
eggs; further species distinction is made by the species of intermediate host snails that 
support transmission of the parasite (Gryseels et al., 2006). 
The global strategy for the control of schistosomiasis is by chemotherapy. Systematic 
searching for chemotherapeutic drugs began almost a century ago, and the development of 
praziquantel (PZQ) in 1970 was essential for a reduction in morbidity and mortality due to 
schistosomiasis. Currently, treatment is still based on the use of PZQ, but the long-term 
application of PZQ results in decreased efficiency and serious concerns regarding the onset 
of resistance. In addition, PZQ has no prophylactic properties and is ineffective against 
larval stages of parasites (schistosomula), meaning that for effective treatment and 
sustainable control, PZQ must be given on a regular basis. Thus, it is prudent to search for 
novel therapeutics, and recent discussions have focused on reawakening the need to search 
for alternatives to PZQ (Caffrey, 2007; Doenhoff et al., 2008; Fenwick et al., 2003; Hagan et 
al., 2004; Keiser & Utzinger, 2007). 
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Natural products, mainly plants, have been the source of medicines for thousands of years. 
The discovery of pure compounds as active principles in plants was first described at the 
beginning of the 19th century, and the art of exploiting natural products has become part of 
the molecular sciences (Kayser et al., 2003). Several extracts or bioactive constituents from 
living organisms have been used in many communities worldwide against parasitic 
diseases, including schistosomiasis, and in the past decades, natural products have attracted 
renewed interest (Kayser et al., 2003; Mølgaard et al., 2001; Ndamba et al., 1994; Sanderson 
et al., 2002; Tagboto & Townson, 2001). 
In vitro screening systems are useful and affordable ways to discover potential anthelmintic 
candidates for in vivo tests (Keiser, 2010; Ramirez et al., 2007; Yousif et al., 2007). Because a 
molecular-target approach is still rarely employed in schistosomicidal drug discovery, a 
more common strategy has been the complementary approach of whole-organism 
phenotypic screening in vitro to measure compound efficacy (Keiser, 2010; Ramirez et al., 
2007; Yousif et al., 2007). In this context, screening for natural products that are active 
against schistosome is important in the establishment of future strategies for new 
antischistosomal drug discovery to control schistosomiasis (Yousif et al., 2007). 
Considerable efforts are ongoing to develop novel schistosomicidal agents. As a result, 
many natural compounds with promising antischistosomal properties have been identified 
(Braguine et al., 2009; de Moraes et al., 2011; Magalhães et al., 2009, 2010; Moraes et al., 2011; 
Mølgaard et al., 2001; Parreira et al., 2010; Sanderson et al., 2002). The efficacy of these new 
compounds against schistosome is defined using three strategies: a) curative, by killing the 
adult worm; b) prophylactic, by killing schistosomula; and c) suppressive, by inhibiting 
worm egg-laying. Thus, several parameters, such as motor activity, tegumental changes, 
and oviposition, are often evaluated as indicators of biological activity and toxicity in 
studies with schistosome species. 
This chapter reviews the present state of in vitro drug screening strategies used to discover 
new compounds active against S. mansoni, the most important species infecting humans, with 
an emphasis on natural products. Also highlighted are the best practices and challenges for 
drug screenings. Furthermore, information is provided about toxicity, susceptible Schistosoma 
stages, and other interesting laboratory studies on potential antischistosomal compounds, both 
natural products and natural product-derived compounds.  
2. Antischistosomal drugs 
For the control of schistosomiasis, which at present is dependent on chemotherapy, it is not 
satisfactory to have only one single effective treatment (Caffrey, 2007; Doenhoff et al., 2008; 
Fenwick et al., 2003). Ideally, other antischistosomal drugs would be available so that the 
classical strategy of alternating treatments to avoid the development of resistance could be 
used. Unfortunately, the other drugs used before the advent of PZQ, oxamniquine and 
metrifonate, are restricted in their use. Metrifonate, a drug that exhibits activity against S. 
haematobium, has recently been withdrawn from the market because of medical, operational, 
and economic criteria (Reich & Fenwick, 2001; Utzinger et al., 2003). Oxamniquine is the 
only alternative antischistosomal drug, but it is effective only against S. mansoni. In the 
1970s, oxamniquine was used for individual and mass treatment of schistosomiasis, with 
satisfactory results regarding efficacy and tolerance. However, its use is currently declining 
and is being replaced by praziquantel (Cioli, 2000; Reich & Fenwick, 2001; Utzinger et al., 
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2001, 2003). As there is currently no available vaccine for this disease in people (Bergquist et 
al., 2008), chemotherapy may now be at a crucial point. 
Chemotherapy against schistosomiasis was reviewed extensively by Cioli et al. (1995), with 
an emphasis on compounds that were used in the past. Additionally, Cioli (1998) 
summarised some interesting laboratory studies on potential antischistosomal compounds 
and the possible emergence of praziquantel-resistant schistosomes. More recently, Ribeiro-
dos-Santos et al. (2006) reviewed results from a comprehensive search of the scientific 
literature for substances and compounds tested for schistosomiasis therapy over the past 
century. The authors gathered information on the therapeutic action in humans or animal 
models and the mechanisms of action of over 40 drugs. 
Briefly, antimonial compounds were introduced in 1918, and this group of drugs has been 
the major point of schistosome chemotherapy for approximately 50 years. However, they 
cause numerous side effects, such as nausea, vomiting, diarrhoea, anorexia, and 
cardiovascular, hepatic, and dermatological disturbances. Lethality from cardiac syncope 
and anaphylactic shock was also reported. Emetine, a drug used to treat amoebiasis, was 
employed in the second decade of the past century, but the doses required against 
schistosomiasis were at the very limit of toxicity. The introduction of 2,3-dehydroemetine 
reduced the toxicity of the parent compound, but patients had to be hospitalised over a 
month for treatment. Thus, the use of 2,3-dehydroemetine as an antischistosomal agent was 
abandoned (Cioli et al., 1995). Only in the 1960s was there a breakthrough in the treatment 
of schistosomiasis, with the rise of metrifonate, nitrofurans, lucanthone, niridazole, 
hycanthone, and, finally, oxamniquine. In the 1970s, several schistosomicidal drugs 
emerged, such as tubercidin, amoscanate, PZQ and its benzodiazepine derivative Ro11-
3128, and oltipraz. Nevertheless, the therapeutic doses of most of these drugs were found to 
cause major side effects. PZQ, an isoquinoline-pyrazine derivative, immediately proved to 
be superior to any other schistosomicidal drug and quickly became the drug of choice in 
most endemic areas (Cioli et al., 1995; Fenwick & Webster, 2006). Because of the reliance on 
a single drug for the treatment and control of schistosomiasis and the considerable concern 
regarding the development of PZQ resistance, it is timely to review potential alternatives, 
with an emphasis on natural products. 
2.1 Antischistosomals: Natural product and natural product-derived compounds 
The use of natural products for curative and therapeutic purposes has a long history, and 
compounds derived from natural products have made a big impact on the pharmaceutical 
industry (Newman, 2003; Newman & Cragg, 2007). In addition to microbes and plants, there 
has been growing interest in other living organisms, such as arthropods and amphibians, as 
important sources of biologically active compounds (Kayser et al., 2003). However, the 
potential for using living beings as sources of new antischistosomal drugs is still poorly 
explored. In recent decades, there has been a growing interest in the scientific community to 
search for extracts and pure compounds, especially those derived from plants, that exhibit 
potential schistosomicidal properties, as one alternative method to the conventional chemical 
control. 
Plants have been traditionally used in the treatment of different diseases, including 
schistosomiasis, especially in Africa and Asia (Ndamba et al., 1994). In general, 
medicinal plants are prepared by traditional healers, who have empirical knowledge and 
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cultural communities throughout the world. For example, in Zimbabwe, Ndamba et al. 
(1994) investigated the herbal remedies used in the treatment of schistosomiasis. Based 
on interviews with 286 traditional healers, they composed a list of 47 plant species most 
widely used to treat urinary schistosomiasis. Based on this survey, the seven most 
commonly used plants, Abrus precatorius (Leguminosae) Ozoroa insignis (Anacardiaceae), 
Dicoma anomala (Cornpositae), Ximenia caffra (Oleaceae), Lannea edulis (Anacardiaceae), 
Elephantorrhiza goetzei (Leguminosae) and Pterocarpus angolensis (Leguminosae), were 
collected, prepared as described by the traditional healers, their efficacy was evaluated 
using laboratory animals previously exposed to S. haematobium cercariae,  and the 
activity from the extract of P. angolensis bark was almost comparable to that of 
praziquantel. Later, Mølgaard et al. (2001) screened extracts of 23 plant species, 
popularly used against schistosomiasis in Zimbabwe, for their anthelmintic effect against 
schistosomula of S. mansoni, and the best results against larval forms were obtained with 
stem and root extracts from Abrus precatorius (Fabaceae) and stem bark from 
Elephantorrhiza goetzei (Mimosaceae). All families and names of the plants that are used 
by traditional healers to treat urinary schistosomiasis in Zimbabwe are described by 
Ndamba et al. (1994). 
Some of the most interesting antischistosomal compounds are derivatives of artemisinin, 
such as artemether and artesunate (Utzinger et al., 2001; Xiao et al., 2002). They are highly 
effective in the treatment of malaria and have also been shown to exhibit antischistosomal 
properties. Artemisinin is a sesquiterpene lactone with an endoperoxide group, which was 
isolated from the leaves of Artemisia annua L. This plant has been used for centuries in 
Chinese traditional medicine as antidote to many different ailments (Lee, 2007; Utzinger et 
al., 2001). Artemisinin has been used as an antimalarial since the early 1970s, and its 
antischistosomal activity was discovered in 1980 by a group of Chinese scientists. In 1982, 
antischistosomal properties were confirmed for artemether, the methyl ether derivative of 
artemisinin. Interestingly, artemether has been shown to be active against immature 
schistosome in experimentally infected animals, but it is less effective against adult 
worms (Utzinger et al., 2001). Significant progress has been made with artemether and its 
potential for the control of schistosomiasis, which has been reviewed by Utzinger et al. 
(2001). The mechanism of action of artemisinin and its derivatives appears to involve an 
interaction with heme, which cleaves the endoperoxide bridge of the drug to produce 
carbon-centred free radicals that then alkylate parasite proteins (Golenser et al., 2006). In 
addition, scanning electron microscopy showed that artemether caused extensive and 
severe damage to the tegument in 21-day-old S. mansoni harboured in mice (Xiao et al., 
2000). Considering that artemether and praziquantel exhibit the highest activity against 
schistosomula and adult worms, respectively, combined treatment has been proposed to 
enhance the reduction in worm burden (Utzinger et al., 2003). Currently, new trials to use 
artemisinin and its synthetic derivatives as lead molecules for drug discovery against 
schistosomiasis and various other diseases are rapidly growing, and the studies are 
ongoing (Lee, 2007; Utzinger et al., 2003, 2007; Xiao et al., 2002). Likewise, research on 
other natural products and natural product-derived compounds against schistosome has 
been performed by many groups. Accordingly, several plants with antischistosomal 
properties have been described in the literature (Braguine et al., 2009; de Moraes et al., 
2011; Magalhães et al., 2009, 2010; Moraes et al., 2011; Mohamed et al., 2005; Mølgaard et 
al., 2001; Parreira et al., 2010; Sanderson et al., 2002).  
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Here, data on natural products and related natural product-derived compounds are 
reviewed, especially those from recent years or that have received considerable attention 
due to their antischistosomal properties (Table 1). 
 
Date * 
Extract/ 
Compound and Biological 
Source 
Relevant notes 
1980 
Artemisinin, active 
principle from the plant 
Artemisia annua L. 
(Asteraceae) 
Artemisinin derivatives: artemether (1982) and 
artenusate (1983); effective against immature 
schistosome in experimentally infected animals; 
morphological alteration on the tegument 
(Utzinger et al., 2001) 
1989 
Extracts from the plant 
Pavetta owariensis P. Beauv
(Rubiaceae) contain 
proanthocyanins 
Effective in mice infected with S. mansoni 
(Baldé et al., 1989) 
1997 
Goyazensolide 
isolated from the plant 
Eremanthus goyazensis 
(Gardner) Sch. Bip. 
(Compositae) 
In vitro activity on Schistosoma adult worms; 
inhibitory effect on egg-laying; female more 
susceptible than male; not tested on schistosomula 
(Barth et al., 1997) 
2000 
Extract of leaf from the 
plant Vernonia amygdalina 
Del (Compositae) 
Active against S. mansoni in mice (Ogboli, 2000) 
2001 
Mirazid 
myrrh, an oleo-gumresin 
from the stem of the plant 
Commiphora molmol 
(Burseraceae) 
There is a great debate about the efficacy and 
effectiveness of myrrh in the treatment of 
schistosome infections, both in laboratory 
and clinical settings (Abdul-Ghani et al., 2009; Badria 
et al., 2001; Botros et al., 2004, 2005; 
Sheir et al., 2001) 
2002 
Oil from the plant Nigella 
sativa L. (Ranunculaceae) 
Active on S. mansoni-infected mice; crushed seed also 
has in vitro effects against S. mansoni miracidia, 
cercariae, and adult worms, and an inhibitory effect 
on egg-laying; not tested on schistosomula 
(Mahmoud et al., 2002; Mohamed et al., 2005) 
2002 
Extract of the seeds and 
isoflavonoids from the 
plant Millettia thonningii 
(Schum. et Thonn.) Baker 
(Leguminosae) 
In vitro against S. mansoni adult worms; no egg 
production was observed for experimental worms; 
not tested on schistosomula. Schistosomicidal 
activity against S. mansoni cercariae and miracidia 
has been previously described (Lyddiard et al., 2002) 
* Dates of introduction or publication are only approximate. 
Table 1. In vitro and in vivo antischistosomal characteristics of natural products. 
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Date * 
Extract/ 
Compound and 
Biological Source 
Relevant notes 
2005 
Extract of rhizomes from 
the plant Zingiber 
officinale Roscoe 
(Zingiberaceae) 
In vitro male worms seemed more susceptible than 
female; reduction in egg output; activity against S. 
mansoni in mice was conflicting between Mostafa 
et al. (2011) and Sanderson et al. (2005); 
morphological alteration on the tegument; not 
tested on schistosomula 
2007 
Extract from plant 
Curcuma longa L. 
(Zingiberaceae) 
Effective on S. mansoni-infected 
mice (El-Ansary et al., 2007; El-Banhawey et al., 
2007); the in vitro schistosomicidal activity of 
curcumin, the major constituent in the rhizome, 
and reduction in egg production has been reported 
(Magalhães et al., 2009) 
2007 
Extract from garlic Allium 
sativum L. (Liliaceae) 
Active against S. mansoni in mice (50 mg/kg) and 
not effective in high dose (100 mg/kg); affects the 
development and maturity of S. mansoni eggs in 
mice and seems to be an agent in protecting 
hepatic tissue against oxidative damage due to S. 
mansoni infection. In vitro allicin (2011), the main 
constituent of garlic, causes alterations on the 
tegument of male worm in high doses (10 to 20 
µg/ml), but toxicity not assessed; not tested on 
schistosomula (El Shenawy et al., 2008; Lima et al., 
2011; Riad et al., 2007) 
2009 
Extract from the plant 
Clerodendrum umbellatum 
Poir (Verbenaceae) 
Effective in S. mansoni mice model (Jatsa et al., 
2009) 
2009 
Extract from the plant 
Zanthoxylum naranjillo 
Griseb (Rutaceae) and its  
isolated compounds 
In vitro against S. mansoni adult worms; reduction 
in egg-laying; not tested on schistosomula; not 
toxic in mammalian cells (Braguine et al., 2009) 
2010 
Phloroglucinol 
compounds from plants 
of the Dryopteris genus 
(Dryopteridaceae) 
In vitro against S. mansoni adult worms; reduction 
in egg-laying; not tested on schistosomula; not 
toxic in mammalian cells (Magalhães et al., 2010) 
2010 
Essential oil from the 
plant of Baccharis 
dracunculifolia DC. 
(Asteraceae) 
In vitro against S. mansoni adult worms; reduction 
in egg-laying; not tested on schistosomula; not 
toxic in mammalian cell (Parreira et al., 2010) 
2011 
Essential oil from plant  
Ageratum conyzoides L. 
(Asteraceae) 
In vitro against S. mansoni adult worms; reduction 
in egg-laying; not tested on schistosomula; not 
toxic in mammalian cells 
(de Melo et al., 2011) 
Table 1. Continued 
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Date * 
Extract/ 
Compound and 
Biological Source 
Relevant notes 
2011 
Sulfated polysaccharide 
α-D-glucan extracted 
from lichen Ramalina 
celastri (Spreng.) Krog. & 
Swinsc 
Effective in S. mansoni-infected mice (Araújo et al., 
2011) 
2011 
Piplartine, an amide 
isolated from plant Piper 
tuberculatum Jacq. 
(Piperaceae) 
In vitro against S. mansoni adult worms; reduction 
in egg-laying; causes alterations on the tegument of 
worms; not tested on schistosomula;  
not toxic in mammalian cells (Moraes et al., 2011) 
2011 
Dermaseptin 01, an 
antimicrobial peptide 
found in the skin of frog 
of the genus Phyllomedusa 
(Hylidae) 
In vitro against S. mansoni adult worms; reduction 
in egg-laying; causes alterations on the tegument of 
worms; not tested on schistosomula;  
not toxic in mammalian cells (de Moraes et al., 
2011) 
2011 
Epiisopiloturin, an 
alkaloid isolated from 
plant Pilocarpus 
microphyllus Stapf ex 
Holm 
(Rutaceae) 
In vitro against S. mansoni adult worms; causes 
alterations on the tegument of worm; not tested on 
schistosomula; not toxic in mammalian cells 
(Leite et al., 2011) 
2011 
Extract from plants of the 
Artemisia genus 
(Asteraceae)  
In vitro against S. mansoni adult worms; not tested 
on schistosomula (Ferreira et al., 2011) 
Table 1. Continued 
As shown in Table 1, several in vitro studies have been conducted to search for new natural 
substances with schistosomicidal activity. These natural products and natural product-
derived compounds mostly come from plants. Extensive phytochemical investigations of 
many species have revealed the presence of a large number of novel compounds belonging 
to different classes (Kayser et al., 2003; Kato & Furlan, 2007; Parmar et al., 1997; Prassad et 
al., 2005). For example, various secondary metabolites have been isolated from the family 
Piperaceae, and these plants have generated great interest as a result of their biologically 
active metabolites, such as pyrones, terpenes, lactones, chromenes, chalcones, lignoids, 
amides, and alkaloids (Kato & Furlan, 2007; Parmar et al., 1997). Regarding the variety of 
biological properties in particular, Moraes et al. (2011) demonstrated the in vitro 
schistosomicidal activity of piplartine, an amide found in several Piper species. The authors 
showed that at low concentrations (9.5 µM) this amide can kill S. mansoni adult worms (male 
and female coupled) and that the sub-lethal concentration of piplartine (6.3 µM) caused a 
75% reduction in egg production. Additionally, piplartine was not cytotoxic against 
mammalian cells when given at concentrations up to three times higher than what is needed 
for a schistosomicidal effect (31.5 µM). Furthermore, Piper species are widely distributed in 
tropical and subtropical regions of the world, and they are among the most important 
medicinal plants used in various systems of medicine (Jaramillo & Manos, 2001; Parmar et 
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al., 1997). In addition to the wide geographical distribution and their use in folk medicine, 
the interest in these compounds and plant extracts is based on the fact that it is easy to 
isolate secondary metabolites and to propagate the plant, which has a short reproductive 
cycle. Thus, considering the in vitro schistosomicidal activity of the amide piplartine, the 
importance of more research on the biological activity of the natural compounds isolated 
from the family Piperaceae and other plants is apparent. 
3. Schistosoma mansoni life cycle and maintenance in the laboratory 
Schistosome species are dioecious (having male and female reproductive organs in separate 
individuals) platyhelminthes and have complex life cycles comprising multiple 
morphologically distinct phenotypes in definitive mammalian and intermediate snail hosts. 
S. mansoni is one of the most common etiological agents of human schistosomiasis and is the 
most widely used schistosome model for chemotherapeutic studies.Schistosome infection of 
humans (or another definitive host) occurs by direct contact with freshwater containing free-
swimming larval forms of the parasite, known as cercariae. Cercariae penetrate the intact 
human skin and transform into schistosomula, which reside in the skin for up to 72 hours 
before entering a blood vessel. Within the vascular system, schistosomula migrate via 
complex routes to their final venous destination, where they mature into male and female 
adults. The mature flukes dwell in the human portal vasculature, depositing eggs in the 
intestinal wall that either pass to the gut lumen and are expelled in the faeces or travel to the 
liver and trigger immune-mediated granuloma formation and peri-portal fibrosis. Egg 
production commences 5 to 6 weeks after infection and continues for the life of the worm. 
The life cycle is completed when the eggs passed in the faeces hatch in the water, releasing 
the larval form miracidia, which then infect freshwater snails of the Biomphalaria spp. The 
infected snails, bearing schistosomal sporocysts, release cercariae into the water, which in 
turn penetrate the skin of their definitive host (Gryseels et al., 2006). 
To complete a life cycle in the laboratory, S. mansoni is commonly maintained using rodents, 
ranging from hamsters to mice, as the definitive hosts and Biomphalaria glabrata as the 
intermediate host snail species (Figure 1). Infections of rodents of the same gender, 3 to 4 
weeks of age and weighing 18 to 25 g, with S. mansoni are commonly initiated by 
subcutaneous injection of 100 to 150 cercariae (infective larvae). At 42, 49 or 56 days 
postinfection, animals are sacrificed with CO2, dissected, and miracidia are hatched from S. 
mansoni eggs taken from animal livers. Each intermediate host snail is exposed to 
approximately 10 miracidia. All animals should be handled in strict accordance with good 
animal practice adhering to the institutional guidelines for animal husbandry. Thus, all 
studies should have a statement from their ethics committee or institutional review board 
indicating the approval of the research. 
The use of in vivo animal models in drug discovery and the techniques used for these studies 
in the laboratory have recently been described in detail elsewhere by Keiser (2010) and 
Ramirez et al. (2007). This chapter will focus on the techniques used for in vitro studies. 
Many methods have been described that aim to determine the antischistosomal activity of 
drugs in vitro. The assessment of the viability of different stages of schistosome, tegumental 
changes, oviposition, toxicity in mammalian cells and other parameters are important in the 
search for antischistosomal substances. The techniques detailed here will be the key to better 
assess the methodology employed during screening tests. 
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4. Parasite culture system 
In vitro studies with schistosomula, juvenile and adult worms of S. mansoni are frequently 
used in screening strategies for the discovery of new antischistosomal drugs (Abdulla et al., 
2009; Keiser, 2010; Mølgaard et al., 2001; Peak et al., 2010; Ramirez et al., 2007; Smout et al., 
2010; Yousif et al., 2007). Parasites at different stages might show differences with regard to 
drug sensitivity. The in vitro methods currently utilised have recently been reviewed, and 
following the establishment of the S. mansoni life cycle in the laboratory, in vitro parasite 
culture techniques were developed (Keiser, 2010; Ramirez et al., 2007). For in vitro trials, 
parasites of different ages are used, such as 3-h-old and 1-, 3-, 5- and 7-day-old 
schistosomula, 21 day-old juveniles, and 42- to 56-day-old adults. Figure 1 shows the life 
cycle of S. mansoni in the laboratory, illustrating the collection points for in vitro 
chemotherapeutic studies. 
 
 
 
Fig. 1. Life cycle of S. mansoni, illustrating the collection points for in vitro chemotherapeutic 
studies. Black arrow: maturation of parasite within final host. Blue arrow: aquatic phase 
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4.1 Juvenile and adult schistosomes 
Adult worms have been more commonly used for antischistosome drug discovery. Today, 
in vitro chemotherapeutic studies using juvenile worms are also highly recommended. For 
these assays, each rodent is commonly infected with either 100-150 or 400-500 cercariae. 
Rodents exposed to 400-500 cercariae are sacrificed 21 days after infection for juvenile 
recovery, while mice exposed to 100-150 cercariae are sacrificed 42 to 56 days after infection 
for adult recovery. Juveniles or adults are collected using a perfusion technique with Hanks’ 
balanced salt solution (HBSS), Dulbecco’s Modified Eagle’s Medium (DMEM), or Roswell 
Memorial Park Institute (RPMI) 1640 medium, containing an anticoagulant such as heparin 
at a concentration range of 5-20 U/ml (Smithers & Terry, 1965). The worms are washed in 
RPMI 1640 medium, kept at pH 7.5 with 25 mM N-2-hydroxyethylpiperazine-N’-2-
ethanesulfonic acid (HEPES) containing 200 U/ml penicillin, 200 µg/ml streptomycin, and 
0.25 µg/ml amphotericin B. After washing, ten to fifteen juveniles or one pair of adult 
worms (male and female coupled) are transferred to each well of a 24-well culture plate 
containing 2 ml of the same medium supplemented with 10% bovine foetal serum and 
incubated at 37 ºC in a humid atmosphere containing 5% CO2. Only viable, contractile 
worms showing total tegument integrity as assessed by light microscopy should be included 
in the different investigations (Figure 2). 
 
 
Fig. 2. In vitro assay models with Schistosoma mansoni adult worms. 
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4.2 Schistosomula 
Obtaining sufficient quantities of schistosomula directly from skin or lung tissue for most 
research purposes is time consuming and involves working with mammalian hosts. These 
difficulties led to the development of techniques for transforming cercariae and 
maintaining schistosomula. In fact, schistosomula can be obtained by transforming 
cercariae using simple techniques, such as centrifugation, vortexing, repeated aspiration 
through a syringe needle, or chemical stimulation, and these schistosomula are easily 
maintained in vitro for several days (Basch, 1981). These in vitro strategies are 
advantageous because they confer uniformity in parasite maturation, which cannot be 
achieved in vivo due to the variation in the time required for individual parasites to 
penetrate the host skin and enter the vasculature. In addition, the use of mechanically 
obtained schistosomula is an alternative method that reduces, refines and replaces the use 
of animals in laboratory research in accordance with animal protection principles 
(Broadhead & Bottrill, 1997). 
Among the techniques available for the production of schistosomula, the current methods 
most commonly used for the removal of tails from cercariae are the repeated aspiration 
through a syringe needle, based on Colley and Wikel (1974), and the use of a Vortex mixer, 
based on Ramalho-Pinto et al. (1974). In our laboratory, for example, schistosomula are 
mechanically transformed according to Ramalho-Pinto et al. (1974) and cultured in vitro in 
169 medium, as described by Bash (1981). This method is recommended over the syringe-
passage technique, which severely stresses and damages the parasites. In addition, the 
mechanical transformation procedure in a Vortex mixer is simpler than the passage of the 
parasites under pressure many times through a needle. Briefly, to obtain cercariae, B. 
glabrata snails infected with miracidia are exposed to incandescent light for 2 h, and then 
cercariae are collected, concentrated in glass conical centrifuge tubes and cooled in a ice bath 
for 10 minutes to reduce the motility of the worms. The ice-cold cercarial suspension is 
centrifuged, resuspended in RPMI 1640 medium with 25 mM HEPES, 200 UI/ml penicillin, 
200 µg/ml streptomycin, and 0.25 µg/ml amphotericin B, and vortexed for 2 minutes to 
trigger tail loss. The resulting cercarial bodies are isolated from free tails by centrifugation 
through a 60% Percoll gradient (Lazdins et el., 1982) or decantation (Ramalho-Pinto et al., 
1974). Microscope examination is used to assess the quantity and quality of purified 
schistosomula. Finally, schistosomula are cultivated in 169 medium containing antibiotics 
and supplemented with 10% bovine foetal serum at 37 ºC in a 5% CO2 atmosphere. 
Schistosomula are cultured until day 7, which corresponds to the lung-stage worm. For in 
vitro drug screening assays, schistosomula are transferred into 96-well culture microplates, 
with approximately 50 parasites per well, and maintained in 200 µl 169 medium under the 
conditions described above. 
After penetrating the definitive host, significant morphological, physiological, and 
biochemical changes occur in the developing schistosomula (Gobert et al., 2007; Skelly & 
Alan Wilson, 2006). Although mechanically transformed schistosomula are different from 
the schistosomula that have penetrated the skin, these larval cultures have been maintained 
in vitro for different amounts of time to produce all the mammalian host stages, including 
skin- and lung-stage schistosomula and paired, mature adult males and females (Basch, 
1981). Mechanically transformed schistosomula are now commonly used in studies of 
behaviour, development, metabolic activity, biochemistry, molecular biology, immunology, 
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and in vaccine development and drug screening protocols (Abdulla et al., 2009; Gobert et al., 
2007; Harrop & Wilson, 1993; Peak et al., 2010). There is evidence that mechanically 
transformed schistosomula are structurally similar to their lung schistosomula counterparts 
(Chai et al., 2006), and after 7 days in culture, the larvae have the morphological features of 
lung worms and are capable of maturation when introduced into the portal vein of mice 
(Harrop & Wilson, 1993). Furthermore, mechanically transformed schistosomula are able to 
develop steadily until adult worm pairing (Basch, 1981). Because of these reasons, drug-
screening assays in our laboratory are based on mechanically transformed schistosomula of 
different ages in vitro (3-h-, 1-, 3-, 5- and 7-day-olds). It takes roughly 3 h for the cercariae to 
secrete the contents of their acetabular glands; the 1- to 7-day-olds correspond to the skin- 
and lung-stage schistosomula. 
5. Operating procedures for antischistosomal drug screening and the 
techniques employed 
In recent years, the search for new anthelmintics has intensified, but little significant 
progress has been made in developing new techniques. The in vitro drug screening 
approaches must take into account some specific concerns, particularly to be simple and 
inexpensive. Important methodologies can objectively and rapidly distinguish helminth 
viability or phenotype. In vitro screening could identify novel anthelmintics and could 
eventually translate into practical applications. Herein, a general overview is given of the 
most common methodologies used for screening antischistosomal compounds and their 
effects on the whole organism. 
5.1 Compound storage and handling 
To test new compounds, including synthetic or natural products and crude extracts or 
fractions of a natural source, it is necessary to consider factors such as solubility and 
stability. The compounds are usually stored in hermetically sealed glass containers, covered 
with aluminium foil to protect the contents from light, and kept refrigerated at 8 ºC or at 
ambient temperature until used. The compounds are commonly dissolved in dimethyl 
sulfoxide (DMSO), which should not exceed a final concentration of 2% in the culture 
medium containing parasites. Control schistosomes are incubated in the presence of the 
highest concentration of solvent used. 
For in vitro screening assays, there is not a set maximum concentration to evaluate the 
activity of compounds on schistosomes, as long as no toxicity occurs on mammalian cells. 
However, in our laboratory, in vitro screenings are performed at final maximum 
concentrations of up to 500 µg/ml for crude extracts or fractions and 1,000 µM for isolated 
compounds. The reference drug praziquantel is used as a positive control at final 
concentrations ranging from 5 to 10 µM (Figure 2). 
5.2 Assessment of parasite viability 
The effects of compounds on S. mansoni are commonly assessed by phenotypic changes. The 
parasites are kept for 5 days as described above, and monitored at different time points (e.g., 
24, 48, 72, 96, and 120 h) to evaluate their general condition, using parameters such as motor 
activity, morphological changes, and mortality rate (Figure 2). 
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Current methods utilised to assess schistosomal viability have recently been reviewed, and 
most of these methods involve microscopic techniques (Keiser, 2010; Ramirez et al., 2007). 
The phenotypic changes are scored by using a viability scale. For example, a scale of 0 – 4, 
where 4= normally active, 3= slowed activity, 2= minimal activity, 1= absence of motility 
apart from gut movements, and 0= total absence of mobility, is based on standard 
procedures for compound screening at the Special Programme for Research and Training in 
Tropical Diseases, World Health Organization, WHO-TDR (Ramirez et al., 2007). 
Alternatively, as described by Manneck et al. (2010, 2011), drug activity is defined as 3= 
totally vital, normally active, and no morphological changes; 2= slowed activity, primary 
morphological changes and visible granularity; 1= minimal activity, severe morphological 
changes and granularity; 0= all worms dead, severe morphological changes and granularity; 
the granularity is characterised only for schistosomula. The regular movement of both larval 
and adult schistosomes has proven to be a valuable trait in assessing schistosome viability in 
vitro because lack of movement is a good indicator of death. Worm death is usually defined 
as no movement observed for at least 2 min of examination (Manneck et al., 2010). In this 
context, the viability of worm during the culture period is also assessed by motor activity 
reduction, and it is defined as "slight " or "significant". This subjective criterion is commonly 
used by several research groups (Braguine et al., 2009; de Melo et al., 2011; de Moraes et al., 
2011; Magalhães et al., 2009, 2010; Moraes et al., 2011, Parreira et al., 2010; Pereira et al., 2011; 
Xiao et al., 2007). Size measurements of parasites are also employed to study phenotypic 
changes. 
In addition to the phenotypic approaches, another in vitro drug-screening assay method is 
based on microcalorimetry. Manneck et al. (2011) analysed the effects of drugs on the 
metabolic activity of schistosomula and adult S. mansoni by comparing their heat flow. In 
this study, a multi-channel isothermal microcalorimeter equipped with 48 measuring 
channels was used to monitor the heat production by schistosomes as a result of their 
metabolism over time. The results show that microcalorimetry can be a valuable tool to 
study antischistosomal drugs, and the microcalorimetric measurements confirmed, in part, 
the results of the phenotypic evaluation. However, the level of agreement between 
microscopy and microcalorimetry data requires further investigation (Manneck et al., 2011). 
In the following section, other methods are described that are used to determine the effect of 
drugs on schistosomula and adult S. mansoni. 
Phenotypic changes are determined as mentioned above. However, because of the lack of 
standardisation between laboratories, the replication of results obtained by microscopic 
means is not always possible. In an effort to avoid the subjective nature of quantifying 
schistosome viability from the microscopic examination of phenotype alone, further 
adaptations have been developed and are based on the differentiating potential of some 
colorimetric vital dyes. Diamidinophenylindole (DAPI) has been used as a differential 
stain of dead schistosomula during microscopy; in addition, the low DAPI concentration 
(1 µg/ml) in the medium proved not to be toxic to the schistosomula, nor did it cause any 
background fluorescence (Van Der Linden & Deelder, 1984). Trypan blue has also been 
shown to be a reliable dye for differentially staining dead schistosomula (Harrop & 
Wilson, 1993) and by means of a methylene blue dye exclusion test (Gold, 1997). The 
tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) is 
also a vital dye that has been successfully used to assess the viability of worms. The use of 
this assay on helminths was pioneered by Comley et al. (1989), and several nematode 
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species have been assessed. Nare et al. (1991) used the MTT marker to evaluate the 
viability of adult schistosomes; currently, some in vitro bioassays used to study the effects 
of drugs have demonstrated the ability of MTT to assess the viability of adult worms 
(Braguine et al., 2009; de Melo et al., 2011; Magalhães et al., 2009, 2010; Parreira et al., 
2010; Pereira et al., 2011). 
Recently, Peak et al. (2010) validated a high-throughput system for detecting the viability 
of schistosomula using a microtiter plate-based method. In this study, the authors 
combined the use of propidium iodide with fluorescein diacetate to allow the easy 
assessment of the percent of viable schistosomula present in a sample. This helminth 
fluorescent bioassay was developed into a method of wide-scale application because it is 
sensitive, relevant to industrial high-throughput (384-well microtiter plate compatibility, 
200 schistosomula/well) and academic (96-well microtiter plate compatibility, 1000 
schistosomula/well) settings, translatable to drug screening assays, does not require a 
priori knowledge of schistosome biology or extensive training in parasite morphology, 
and is objective and quantitative. 
The development of high-content screening systems is an important step for the 
assessment of parasite viability in a high-throughput format. A novel assay for 
anthelmintic drug screening by real-time monitoring of parasite motility was developed by 
Smout et al. (2010). This technological advance is based on the detection of changing 
electrical currents running through mini gold electrodes on the bottom of tissue culture 
plates. In this assay, the authors assessed the motility of S. mansoni using an xCELLigence 
system (Real Time Cell Assay, RTCA SP instrument), which monitors cellular events in real 
time without the incorporation of labels by measuring the electrical impedance across 
interdigitated micro-electrodes integrated on the bottom of tissue culture plates. This 
technology was applied to adult schistosome using one pair (one coupled male and 
female worm) in 200 µl per well of an E-plate, which is a 96-well plate for cell-based 
assays on the RTCA instruments. Because the real-time system measures changes in worm 
motility with the high level of precision necessary for high-throughput studies, it is 
widely applicable to a range of helminth species and developmental stages (Smout et al., 
2010). This motility assay may provide a superior methodology to microscopy by 
removing the subjectivity from helminth phenotype characterisation and making 
available a technology that could allow the direct comparison of results from different 
laboratories. However, the initial cost of this RTCA system and E-plates may restrict its 
use, especially in an academic laboratory. 
5.3 Assessment of changes in the tegument of parasites 
The tegument is the major interface between the schistosome and its external environment. 
In addition to providing protection, the tegument is an important site of the uptake of 
nutrients and other molecules. Moreover, the tegument is extremely important for infection 
success and survival in the host, and it has been a major target for the development of 
antischistosomal drugs (Skelly & Wilson, 2006; Van Hellemond et al., 2006). Therefore, most 
of the drugs currently used against schistosome act by damaging the worm tegument 
(Doenhoff et al., 2008; Fenwick et al., 2003; El Ridi et al., 2010; Keiser, 2010; Manneck et al., 
2010, 2011; Mostafa et al., 2011; Xiao et al., 2000). 
The schistosome tegument is often approached as a drug target in schistosomiasis and is 
associated with the subjective assessment of parasite viability described here. The 
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morphological alterations of the tegument of S. mansoni are also assessed by methods that 
involve microscopic analysis. Indeed, during the assay, the parasite is manipulated in vitro, 
and the effect of such manipulation is assessed by bright-field examination of the 
morphology of the parasite (Figure 2). The criteria used to assess morphological changes 
induced by a drug require visual scoring by skilled operators and is assessed subjectively. 
Morphological changes are usually defined qualitatively as "partial" or "extensive" 
(Braguine et al., 2009; de Melo et al., 2011; de Moraes et al., 2011; Magalhães et al., 2009, 
2010; Moraes et al., 2011; Parreira et al., 2010; Pereira et al., 2011; Xiao et al., 2007). Therefore, 
the effect of anthelmintic drugs on the tegument of schistosome cannot be evaluated in a 
dose-dependent manner. In addition, a question remains: is the death of the parasite is 
associated with damage to the coat? 
The inherent subjectivity of this qualitative analysis led Moraes et al. (2011) and de Moraes 
et al. (2011) to develop a quantitative method for evaluating the effect of drugs on the 
tegument of S. mansoni using confocal microscopy. In this quantitative analysis, areas of the 
tegument of male worms are assessed, and the numbers of tubercles are counted. Briefly, the 
parasites are fixed in Formalin-Acetic-Alcohol solution (FAA) and analysed under a 
confocal microscope at 488 nm (excitation) and 505 nm (emission), as described by Moraes et 
al. (2011) and de Moraes et al. (2011). During the microscopic analysis of the three-
dimensional images captured using LSM Image Browser software (Zeiss), areas of the 
tegument of parasite are assessed, and the numbers of tubercles on the dorsal surface of 
male helminths are counted in a 20,000 µm2 area, which is calculated using the same 
software image capture. Importantly, the area chosen is in the dorsal region of the male 
adult worm, close to the ventral sucker (acetabulum) region, because there is no significant 
variation in the number of tubercles in this region. Furthermore, schistosome and others 
trematodes are self-fluorescent (Moraes et al., 2009), and this fluorescence is increased when 
the parasites are in the FAA solution. This is advantageous because it allows images to be 
captured without using a fluorescent fluorophore. The FAA solution consists of a 2:9:30:59 
mixture of acetic acid, formaldehyde, ethanol (95%) and distilled water. This methodology is 
summarised in Figure 3. 
As previously mentioned, drug effects are currently assessed by observing morphological 
changes in parasites using light microscopy methods. However, these techniques do not 
allow the microscopic analysis of the tegument in detail. The quantitative analysis described 
by Moraes et al. (2011) and de Moraes (2011) must be performed with high-resolution 
microscopy, such as confocal or scanning electron microscopy. Therefore, the drug effects 
assessed by phenotypic changes, such as tegumental alterations, cannot be trusted. For 
example, Moraes et al. (2011) used confocal microscopy to evaluate the in vitro 
schistosomicidal activity of piplartine, an amide isolated from Piper tuberculatum, and 
demonstrated that the tegumental damage occurs after incubation with doses higher than 
the lethal concentrations, suggesting that worm death is caused by different mechanisms. 
Thus, tegumental damage may not always result in death, and a quantitative assessment 
technique is needed to understand the mechanisms of action of newly discovered 
antischistosomal drugs. In addition, the advent of screening methods that allow high-
throughput, scalable, automated, and objective assays for helminth viability, combined with 
knowledge of the molecular biology of the schistosome to identify possible new drug 
targets, will make drug development for schistosomiasis easier. 
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Fig. 3. Dorsal region of a Schistosoma mansoni adult male worm, on which the effect of 
antischistosomal compounds on the tegument is evaluated quantitatively. The parasite was 
fixed in FAA solution, and fluorescent images were obtained using a confocal microscope. 
A: General view of the anterior helminth region showing, in red, the location where 
tubercles were counted. Bar = 500 µm. B: View of an area of 20,000 µm2, calculated with the 
Zeiss LSM Image Browser software, showing the tubercles. This image is a higher 
magnification of the dorsal region of the S. mansoni adult worm marked in red in panel A. X 
and Y: three-dimensional images obtained from laser scanning confocal microscopy. Os: oral 
sucker; Vs: ventral sucker; Tu: tubercles 
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5.4 In vitro assessment of the reproductive fitness of adult worms 
The effects of natural or synthetic products on the reproductive fitness of S. mansoni have 
been previously reported in several studies (Braguine et al., 2009; de Moraes et al., 2011; 
Magalhães et al., 2009, 2010; Mohamed et al., 2005; Moraes et al., 2011; Sanderson et al., 
2002). To evaluate drug effects on schistosome during in vitro screening drug assays, 
cultures are continually monitored to assess the sexual fitness of worms treated with sub-
lethal concentrations of drug. In this case, the following parameters are assessed: (1) changes 
in the pairing, an indicator of the mating process; (2) egg production, an indicator of egg 
output per worm; and (3) egg development. 
In the experiments, adult worm pairs (male and female coupled) are incubated in a 24-well 
culture plate, as previously described here, and parasites are monitored on daily basis for 5 
days using an inverted microscope and a stereomicroscope (Figure 2). Therefore, it is 
important that, after collection by the perfusion technique, the parasites are carefully 
washed to prevent the separation of the worm pairs. 
Schistosome egg output in vitro is usually determined by counting the number of eggs. Egg 
development can be analysed quantitatively and scored as developed or undeveloped on 
the basis of the presence or absence of the miracidium (de Melo et al., 2011; Magalhães et al., 
2009, 2010). This is a simple and recommended method because conventional light 
microscopy is able to distinguish morphologic differences in eggs. However, the 
characterisation of the viability of immature eggs is very difficult. Alternatively, the analysis 
of egg viability, distinguishing live immature eggs from dead immature ones, can be 
performed using a fluorescent label, as described by Sarvel et al. (2006). In this assay, the 
eggs obtained in culture are stained with the Hoescht 33258 probe and observed with 
fluorescent microscopy. The authors evaluated fluorescent labels and vital dyes, aiming at 
differentiating live and dead eggs, and showed the only the fluorescent Hoechst 33258 can 
be considered a useful tool to differentiate between dead and live eggs. 
5.5 Cytotoxicity assays 
Finding a new compound capable of killing a parasite is not difficult. However, it is difficult 
to find a substance that can kill the parasite without affecting the host. Therefore, early in 
vitro studies of new compounds must include comparative cytotoxicity data from human or 
animal cells in tissue culture to establish that the compound has selective antischistosomal 
activity and may be a realistic prospect for future clinical use in humans. In our operating 
procedures for antischistosomal drug screening, mammalian cells are exposed to 
concentrations of at least two times higher than what is needed to elicit a schistosomicidal 
effect. Thus, the in vitro schistosomicidal activity of compounds cannot be associated with 
cytotoxic effects. 
General toxicity tests can be conducted in many cell types (e.g., fibroblasts and epithelial 
and hepatoma cells). Peripheral blood mononuclear cells and erythrocytes are widely used 
in in vitro studies to detect cytotoxicity or cell viability following exposure to 
antischistosomal compounds. Vero mammalian cells (African green monkey kidney 
fibroblasts) are also commonly used to examine whether natural or synthetic antiparasitic 
compounds are tolerated by mammalian cells (da Silva Filho et al., 2009; Moraes et al., 2011; 
Parreira et al., 2010). 
The crystal violet staining method and the neutral red and MTT assays are the most 
common methodologies used to detect cytotoxicity or cell viability following exposure to 
toxic substances. In our in vitro cytotoxicity assays with cultured cells, the crystal violet 
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staining method is routinely used because it is rapid and inexpensive. This method 
measures the effects of compounds on cell growth through the colorimetric evaluation of 
fixed cells stained with crystal violet. Briefly, cells maintained in culture medium are seeded 
into 96-well culture microplates in the presence of different concentrations of extracts, 
fractions or isolated compounds. After different timepoints of incubation (e.g., 2, 24, 48, 72, 
and 96 h), the supernatants are removed and the remaining live cells are assessed by fixing 
and staining them with crystal violet (0.2% in 20% methanol). Viable cells attach to the 
bottom of the well plate, and the absorbance is measured by reading each well at 595 nm in 
a microplate reader (Moraes et al., 2011). 
Neutral red is another cell viability assay often used to determine cytotoxicity following 
exposure to toxic substances (Borenfreund & Puerner, 1985). It has been used as an indicator 
of cytotoxicity in cultures of primary hepatocytes and other cell lines (Fautz et al., 1991; 
(Fotakis & Timbrell, 2006; Morgan et al., 1991). Living cells take up the neutral red, which is 
concentrated within the lysosomes of cells. 
The MTT assay is also used to measure cell viability. MTT is a water-soluble tetrazolium 
salt, which is converted to an insoluble purple formazan upon the cleavage of the 
tetrazolium ring by succinate dehydrogenase within the mitochondria. The formazan 
product is impermeable to the cell membranes, and therefore, it accumulates in healthy 
cells. The MTT assay has been tested for its validity in various cell lines (Fotakis & Timbrell, 
2006; Mossmann, 1983). 
Alternatively, the lactate dehydrogenase (LDH) leakage assay and protein assay are also 
used to detect cytotoxicity, despite the fact that they have low sensitivity when compared to 
the methods already described. The LDH leakage assay is based on the measurement of 
LDH activity in the extracellular medium. The loss of intracellular LDH and its release into 
the culture medium is an indicator of irreversible cell death due to cell membrane damage 
(Decker & Lohmann-Matthes, 1988; Fotakis & Timbrell, 2006). The protein assay is an 
indirect measurement of cell viability because it measures the protein content of viable cells. 
Despite the existence of several protocols to establish total protein concentration (e.g., biuret, 
bicinchoninic acid, Lowry and Bradford protocols), the two most commonly used methods 
for protein quantification are the Lowry and Bradford assays (Bradford et al., 1976; Lowry et 
al., 1951). 
Finally, tritiated thymidine-based methods, which act through the incorporation of tritium 
into the DNA of cells, have also been used currently to detect cytotoxicity, especially in 
immune cells (Pechhold et al., 2002). 
6. Conclusions 
Schistosomiasis is a neglected disease that is one of the most common chronic infections 
among the poorest people in the world. Most chemotherapeutic-based programs attempting 
to eradicate schistosomiasis in the developing world rely on the effectiveness of a single 
drug, praziquantel; therefore, there is an urgent need to identify new parasite targets and 
effective antischistosomal compounds. Secondary plant metabolites have attracted the 
attention of many researchers over the years as a result of the variety of their chemical 
structures and their broad range of biological activities that may provide lead structures for 
the development of new drugs. Recently, marine organisms have also been recognised as an 
attractive source of antiparasitic compounds, and it can be expected that other living 
organisms, such as insects and amphibians, will emerge as additional sources in the future. 
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Discovering untapped natural sources of new anthelmintic compounds remains a major 
challenge and a source of novelty in the era of combinatorial chemistry and genomics. To 
find new anthelmintics, all sources of natural, synthetic and semi-synthetic lead compounds 
must be investigated. In vitro bioassays using parasitic worms have played a central role in 
the early pre-clinical stages of most research on potential natural anthelmintics. The 
identification of the antiplasmodial and antischistosomal activity of the sesquiterpene 
lactone artemisinin has stimulated interest in natural products, and soon, promising leads 
will be identified with new chemical types and active agents against schistosomiasis. 
Therefore, bioprospecting programmes related to the isolation of bioactive compounds must 
be rewarded, and the screening in vitro of chemical constituents belonging to different 
classes must be evaluated on the blood fluke S. mansoni. 
The literature regarding antischistosomal compounds contains a large number of natural 
products screened for their schistosomicidal properties. However, only a few of these may 
be promising drug leads in the development of a therapeutic reserve for schistosomiasis. 
Therefore, it is important to continue to identify new drugs and to explore alternative 
strategies to improve screening efficacy. Most of the extracts or natural compounds were 
only evaluated with in vitro studies; it is expected that they will be evaluated using in vivo 
experimental models. Further, it must be mentioned that the results of in vitro assays with 
many drugs do not correspond to what is observed in vivo; however, in vitro screening could 
identify novel anthelmintics that could eventually translate into practical applications. Thus, 
while in vitro tests are recommended initially, the assessment of therapeutic activity using in 
vivo models should be performed. 
The analysis of the S. mansoni genome and transcriptome offers great possibilities for 
identifying possible new drug targets and will facilitate further exploration of differences 
between host and parasite metabolic pathways. In addition to the isolation and structural 
determination of new drugs from natural products and information from the originating 
plant, the integration of the pharmacological properties of natural products with the 
functional genomic and proteomic studies in schistosome and in vitro screening methods 
with improved automatic high-content screening will be important tools to identify possible 
new drugs in the future and shed light on the approaches of helminth chemotherapy. 
Attempting new combinations of natural or synthetic drugs will be also important in 
discovering alternative drugs to replace the use of praziquantel. 
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